Fideuram - Intesa Sanpaolo Private Banking’s Quest Diagnostics DGX Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.12M	Buy	+5,273	New	+$1.03M	0.03%	278

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's DGX Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking opened a new position in Quest Diagnostics (DGX) in Q2 2026: 5,273 shares worth $1.12M. The stake represents 0.03% of the portfolio and ranks #278 among its holdings.

1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Fideuram - Intesa Sanpaolo Private Banking held 5,273 shares of Quest Diagnostics worth $1.12M as of Q2 2026.
Quest Diagnostics was a new Fideuram - Intesa Sanpaolo Private Banking position in Q2 2026.
Quest Diagnostics made up 0.03% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #278 holding.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.